동국제약

086450KOSDAQ

69.9 / 100

Reference Date: 2026-09-08

Financial Score28.0 / 40

News Sentiment17.9 / 25

Momentum14.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Rose 7.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dongkook Pharmaceutical, established in 1968, aims to become South Korea's leading total healthcare group by focusing on new product development and global market expansion. The company offers a wide range of products in over-the-counter drugs, specialty pharmaceuticals, and healthcare sectors, and has successfully exported its products to countries such as China, Japan, and Europe.

Number of Employees

1,306people

Average Salary

67.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

13.99Industry Average 15.005.0Point

In line with industry avg

PBR

1.23Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

10.25Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

4.16Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲12.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲20.2% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 9.7% (improving, 3yr)

Detailed News Sentiment

25 totalPositive 17Neutral 8Negative 0Average Sentiment Score 71.6

Positive
무신사 뷰티, K더마 강화해 올영과 경쟁
동국제약의 입점으로 무신사 뷰티 홍대점이 두피 및 트러블 전문 존을 강화하여 K뷰티 시장에서 경쟁력을 강화하고 있다.
Neutral
“추석 선물 미리 준비하세요”…네이버·쿠팡·SSG ‘할인 전쟁’ 붙.....
온라인 유통업체들의 추석 프로모션 확대가 언급되었으나 동국제약과 직접적인 연관성이 없다.
Positive
동국제약, '마데카 크림 코어 볼류밍' 출시
동국제약의 신제품 '엑스퍼트 마데카 크림 코어 볼류밍' 출시로 인해 더마코스메틱 시장에서의 경쟁력 강화와 브랜드 인지도 상승이 예상됩니다.

Detailed Momentum

52-week position3.0Point

52w lower range (32%)

Current 20,800Won52-week high 29,90052-week low 16,420

1-month return5.0Point

1m +7.77% (rising)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14